Cerebral energy metabolism and blood flow: Useful tools for the understanding of the behavioral effects of caffeine

Caffeine and Behavior: Current Views & Research Trends: Current Views and Research Trends

Volumn , Issue , 2020, Pages 31-47

  Nehlig, Astrid ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85108743408     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780429271038-3     Document Type: Chapter

References (75)

1. Nehlig, A., Daval, J. L., and Debry, G., Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects, Brain Res. Rev., 17, 139, 1992.
2. Nehlig, A. and Debry, G, Effects of coffee on the central nervous system, in Coffee and Health, Debry, G., Ed., John Libbey, Paris, 1994, 157.
3. Fredholm, B. B., On the mechanism of action of caffeine and theophylline, Acta Med. Scand., 217, 149, 1985.
4. Daly, J. W., Mechanism of action of caffeine, in Coffee, Caffeine and Health, Garattini, S., Ed., Raven Press, New York, 1993, 97.
5. Kuschinsky, W., Coupling of function, metabolism and blood flow in the brain, News Physiol. Sci., 2, 217, 1987.
6. Winn, H. R., Rubio, G. R., and Berne, R. M., The role of adenosine in the regulation of cerebral blood flow, J. Cereb. Blood Flow Metab., 1, 239, 1981.
7. McCulloch, J., Kelly, P. A. T., and Ford, I., Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis), J. Cereb. Blood Flow Metab., 2, 487, 1982.
8. Raichle, M. E., Grubb, R. L., Gado, M. H., Eichling, J. O., and Ter-Pogossian, M. M., In vivo correlations between regional cerebral blood flow and oxygen utilization in man, Acta Nenrol. Scand., 56, 240, 1977.
9. Sokoloff, L., Relationship among local functional activity, energy metabolism and blood flow in the central nervous system, Fed. Proc, 40, 2311, 1981.
10. Grome, J. J. and Harper, A. M., The effects of quipazone, a putative serotonin agonist on local cerebral blood flow and glucose utilization in the rat, and pial vascular diameter in the cat, J. Cereb. Blood Flow Metab., 3, Suppl. 1, S302, 1983.
11. Kelly, P. A. T. and McCulloch, J., The effect of GABAergic agonist muscimol upon the relationship between cerebral blood flow and glucose utilization, Brain Res., 258, 338, 1983.
12. Sokoloff, L., Reivich, M., Kennedy, C, Des Rosiers, M. H., Patlak, C. S., Petti-grew, K. D., Sakurada, Ov and Shinohara, M., The P4C]2-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in conscious and anesthetized albino rats, J. Neurochem., 28, 897, 1977.
13. Arluison, M., Agid, Y., and Javoy, R, Dopaminergic nerve endings in the neostriatum of the rat. I. Identification by intracerebral injections of 6-hydroxydopamine, Neuroscience, 3, 657, 1978.
14. Ungerstedt, U., Stereotaxic mapping of the monoamine pathways in the rat brain, Acta Physiol. Scand., Suppl. 367, 69, 1971.
15. Grome, J. J. and Stefanovich, V., Differential effects of xanthine derivatives on local cerebral blood flow and glucose utilization in the conscious rat, in Adenosine: Receptors and Modulation of Cell Function, Stefanovich, V., Rudolphi, K., and Schubert, P., Eds., IRL Press Ltd., Oxford, 1985, 453.
16. Grome, J. J. and Stefanovich, V., Differential effects of methylxanthines on local cerebral blood flow and glucose utilization in the conscious rat, Naun-yn-Schmiedebergs Arch. Pharmacol, 333, 172, 1987.
17. Nehlig, A., Lucignani, G, Kadekaro, M., Porrino, L. J., and Sokoloff, L., Effects of acute administration of caffeine on local cerebral glucose utilization in the rat, Eur. J. Pharmacol, 101, 91, 1984.
18. Nehlig, A., Daval, J. L., Boyet, S., and Vert, R, Comparative effects of acute and chronic administration of caffeine on local cerebral glucose utilization in the conscious rat, Eur. J. Pharmacol, 129, 93, 1986.
19. Nehlig, A., Pereira de Vasconcelos, A., Collignon, A., and Boyet, S., Comparative effects of caffeine and L-phenylisopropyladenosine on local cerebral glucose utilization in the rat, Eur. J. Pharmacol, 157, 1, 1988.
20. Okada, M, Mizuno, K, and Kaneko, S., Adenosine Al and A2 receptors modulate extracellular dopamine levels in rat striatum, Neurosci. Lett., 212, 53, 1996.
21. Okada, M., Kiryu, K., Kawata, Y, Mizuno, K., Wada, K., Tasaki, H., and Kaneko, S., Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis, Eur. J. Pharmacol, 321, 181, 1997.
22. Hirsh, K., Forde, J., and Chou, D. T., Effects of caffeine and amphetamine S04 on single unit activity in the caudate nucleus (abstract), Soc. Neurosci. Abstr., 8, 898, 1982.
23. Popoli, P., Caporali, M. G, and Scotti de Carolis, A., Akinesia due to catecholamine depletion in mice is prevented by caffeine: Further evidence for an involvement of adenosinergic system in the control of motility, J. Pharm. Pharmacol, 43, 280, 1991.
24. Snel, J., Coffee and caffeine: Sleep and wakefulness, in Coffee, Caffeine and Health, Garattini S., Ed., Raven Press, New York, 1993, 255.
25. Jouvet, M., Benoit, O., Marsallon, A., and Courjon, J., Action de la cafeine sur l’activite electrique cerebrale, C. R. Soc. Biol, 151, 1542, 1957.
26. Forde, J. H. and Hirsh, R. K., Caffeine effects on reticular formation neurons in the decrebrate cat (abstract), Soc. Neurosci. Abstr., 2, 867, 1976.
27. Hirsh, K., Forde, J., and Pinzone, M., Caffeine effects on spontaneous activity of reticular formation neurons (abstract), Soc. Neurosci. Abstr., 257, 1974.
28. Chou, D. T., Forde, J. H., and Hirsh, K. R., Unit activity in medial thalamus: comparative effects of caffeine and amphetamine, J. Pharmacol Exp. Therap., 213, 580, 1980.
29. Foote, W. E., Holmes, P., Prichard, A., Hatcher, C, and Mordes, J., Neurophys-iological and pharmacodynamic studies on caffeine and on interactions between caffeine and nicotinic acid in the rat, Neuropharmacology, 17, 7, 1978.
30. Hirsh, K., Central nervous system pharmacology of the dietary methylxanthines, in The Methylxanthines Beverages and Food: Chemistry, Consumption and Health Effects, Spiller, G. A., Ed., Alan Liss, New York, 1984, 235.
31. Gerson, S. C. and Baldessarini, R. J., Motor effects of serotonin in the central nervous system, Life Sci., 27, 1435, 1980.
32. Jouvet, M., Biogenic amines and the states of sleep, Science, 163, 32, 1969.
33. Griffiths, R. R. and Woodson, P. P., Caffeine physical dependence: a review of human and laboratory animal studies, Psychopharmacology, 94, 437, 1988.
34. Griffiths, R. R. and Mumford, G. K., Caffeine reinforcement, discrimination, tolerance and physical dependence in laboratory animals and humans, in Handbook of Experimental Pharmacology, Vol. 118, Schuster, C. R. and Kuhar, M. J., Eds., Springer Verlag, Heidelberg, 1996, 315.
35. Heishman, S. J. and Henningfield, J. E., Stimulus functions of caffeine in humans: Relation to dependence potential, Neurosci. Biobehav. Ren, 16, 273, 1992.
36. Holtzman, S. G., Caffeine as a model drug of abuse, Trends Pharmacol. Sci., 11, 355, 1990.
37. Strain, E. C, Mumford, G. K., Silverman, K., and Griffiths, R. R., Caffeine dependence syndrome. Evidence from case histories and experimental evaluations, JAMA, 272, 1043, 1994.
38. Self, D. W. and Nestler, E. J., Molecular mechanisms of drug reinforcement and addiction, Annu. Rev. Neurosci, 18, 463, 1995.
39. Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W, and Wohltmann, C, Specificity in the projection patterns of accumbal core and shell in the rat, Neuroscience, 41, 89, 1991.
40. Pontieri, F. E., Tanda, G., and DiChiara, G., Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the “shell” as compared with the “core” of the rat nucleus accumbens, Proc. Natl. Acad. Sci. U.S.A., 92, 12304, 1995.
41. Pontieri, F. E., Tanda, G, Orzi, F, and Dichiara, G, Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs, Nature, 382, 255, 1996.
42. Tanda, G, Pontieri, F. E., and DiChiara, G, Cannabinnoid and heroin activation of mesolimbic dopamine transmission by a common m opioid receptor mechanism, Science, 276, 2048, 1997.
43. Koob, G. R, Drugs of abuse: anatomy, pharmacology and function of reward pathways, Trends Pharmacol. Sci, 13, 177, 1992.
44. Tanda, G, Loddo, P., Frau, R., Acquas E., and DiChiara, G, Effect of intravenous caffeine on limbic and cortical dopamine transmission in the rat: a microdialysis study, Proceedings of the 6th International Symposium on Adenosine and Adenine Nucleotides, Ferrara, Italy, May 19-24, 1998.
45. Porrino, L. J., Domer, F. R., Crane, A. M., and Sokoloff, L., Selective alterations in cerebral metabolism within the mesocorticolimbic dopaminergic system produced by acute cocaine administration in rats, Neuropsychopharmacology 1, 109, 1988.
46. Stein, E. A. and Fuller, S. A., Selective effects of cocaine on regional cerebral blood flow in the rat, J. Pharmacol. Exp. Therap., 262, 327, 1992.
47. Sakurada, O., Kennedy, C, Jehle, J., Brown, J.D., Carbin, G.L., and Sokoloff, L., Measurement of local cerebral blood flow with [Qiodoantipyrine, Am. J. Physiol, 234, H59, 1978.
48. Cameron, O. G., Modell, J. G, and Hariharan, M., Caffeine and human cerebral blood flow: a positron emission tomography study, Life Sci., 47, 1141, 1990.
49. Mathew, R. J., Barr, D. L., and Weinman, M. L., Caffeine and cerebral blood flow, Br. J. Psychiat, 143, 604, 1983.
50. Mathew, R. J. and Wilson, W. H., Caffeine induced changes in cerebral circulation, Stroke, 16, 814, 1987.
51. Mathew, R. J. and Wilson, W. H., Behavioral and cerebrovascular effects of caffeine in patients with anxiety disorders, Acta Psychiatr. Scand., 82, 17, 1990.
52. Nehlig, A., Pereira de Vasconcelos, A., Dumont, I., and Boyet, S., Effects of caffeine, L-phenylisopropyladenosine and their combination on local cerebral blood flow in the rat, Eur. J. Pharmacol, 179, 271, 1990.
53. Puiroud, S., Pinard, E., and Seylaz, J., Dynamic cerebral and systemic circulatory effects of adenosine, theophylline and dipyridamole, Brain Res., 453, 287, 1988.
54. Mathew, R. J. and Wilson, W. H., Caffeine consumption, withdrawal and cerebral blood flow, Headache, 25, 305, 1985.
55. Ward, N., Whitney, C, Avery, D., and Dunner, D., The analgesic effect of caffeine in headache, Pain, 44, 151, 1991.
56. Couturier, E. G. M., Hering, R., and Steiner, T. J., Weekend attacks in migraine patients: caused by caffeine withdrawal?, Cephalalgia, 12, 99, 1992.
57. Fennelly, M., Galletly, D. C, and Purdie, G. I., Is caffeine withdrawal the mechanism of postoperative headache?, Anesth. Analg., 72, 449, 1991.
58. Nikolajsen, L., Larsen, K. M., and Kierkegaard, O., Effect of previous frequency of headache, duration of fasting and caffeine abstinence on perioperative headache, Br. J. Anaestk, 72, 295, 1994.
59. Hampl, K. R, Schneider, M. C, Ruttimann, U., Ummenhofer, U., and Drewe, J., Perioperative administration of caffeine tablets for prevention of postoperative headaches, Can. J. Anaesth., 42, 789, 1995.
60. Weber, J. G, Ereth, M. H., and Danielson, D. R., Perioperative ingestion of caffeine and postoperative headache, Mayo Clin. Proc, 68, 842, 1993.
61. Weber, J. G, Klindworth, J. T., Arnold, J. J., Danielson, D. R., and Ereth, M. K., Prophylactic intravenous administration of caffeine and recovery after ambulatory surgical procedure, Mayo Clin. Proc, 72, 621, 1997.
62. Kuschinsky, W, Regulation of cerebral blood flow: An overview, inNeurophys-iological Basis of Cerebral Blood Plow Control: An Introduction, Mraovitch S. and Sercombe, R., Eds., John Libbey, London, 1996, 245.
63. Kuschinsky, W, Adenosine and cerebral blood flow, in Role of Adenosine in Cerebral Metabolism and Blood Flow, Stefanovich, V. and Okyayuz-Baklouti, I., Eds., VNU Science Press, Utrecht, 1987, 95.
64. Hoffman, W. E., Albrecht, R. R, and Miletich, D. J., The role of adenosine in CBF increases during hypoxia in young vs. aged rats, Stroke, 15, 124, 1984.
65. Morii, S., Ngai, A. C, Ko, K. R., and Winn, H. R., Role of adenosine in regulation of cerebral blood flow: effects of theophylline during normoxia and hypoxia, Am. Physiol, 253, H165, 1987.
66. Pinard, E., Puiroud, S., and Seylaz, J., Role of adenosine in cerebral hypoxic hyperemia in the unanesthetized rabbit, Brain Res., 481, 124, 1989.
67. Phillis, J. W., Preston, G., and DeLong, R. E., Effects of anoxia on cerebral blood flow in the rat brain: evidence for a role of adenosine in autoregulation, J. Cereb. Blood Flow Metab., 4, 586, 1984.
68. Phillis, J. W., DeLong, R. E., and Towner, J. K., Adenosine deaminase inhibitors enhance cerebral anoxic hyperemia in the rat, J. Cereb. Blood Flow Metab., 5, 295, 1985.
69. Emerson, T. E., Jr. and Raymond, R. M., Involvement of adenosine in cerebral hypoxic hyperemia in the dog, Am. J. Physiol, 241, HI34, 1981.
70. Pinard, E., Riche, D., Puiroud, S., and Seylaz, J., Theophylline reduces cerebral hyperemia and enhances brain damage induced by seizures, Brain Res., 511, 303, 1990.
71. Sutherland, G. R., Peeling, J., Lesiuk, H. J., Brownstone, R. M., Rydzy, M., Saunders, J. K., and Geiger, J. D., The effects of caffeine on ischemic neuronal injury as determined by magnetic resonance imaging and histopathology, Neuroscience, 42, 171, 1991.
72. Grobbee, D. E., Rimm, E. B., Giovannucci, E., Colditz, G, Stampfer, M., and Willett, W., Coffee, caffeine, and cardiovascular disease in men, N. Engl. J. Med., 323, 1026, 1990.
73. Longstreth, W. T. and Nelson, L. M., Caffeine and stroke (Letter). Stroke, 23, 117, 1992.
74. Curatolo, P. W. and Robertson, D., The health consequences of caffeine, Ann. Int. Med., 98, 641, 1983.
75. James, J. E., Caffeine and Health, Academic Press, London, 1991.